Efficacy Study of Substitution of Darunavir/Ritonavir (DRV/r) for Dual-boosted Protease Inhibitors

NCT00543101 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Darunavir (DRV/r)
DRUG: continue on current dual boosted PI

Sponsor

Community Research Initiative of New England